Skip to content
Home/Companies/Biotech/SynAct Pharma

SynAct Pharma

Biotech·Denmark·Exited 2016·Held 4yr
Entry
2012
Hold
4yr
Exit
2016

Who owns SynAct Pharma?

SynAct Pharma was owned by Capnova through CAPNOVA (1998 vintage) from 2012 to 2016, exited via IPO.

Hand-verified · updated 2026-08-19

Capnova
Investor
Capnova
CAPNOVA · 1998 · VC

Key facts

HQDenmark
SectorBiotech
StatusAcquired
Exit Type
IPO
Buyer
–
MOIC
–
Exit Year
2016

More from CAPNOVA

Other portfolio companies in the same fund.

Triband
Exited 2020
GamingDenmark· 2016
to
SYBO Games
Exited 2012
GamingDenmark· 2011
Action Pharma
Exited 2012
BiotechDenmark· 2002
to
MediConnect
Exited 2005
HealthTechDenmark· 2001
to
Aros Applied Biotechnology
Exited 2013
BiotechDenmark· 2000
to

More PE-backed in Biotech

Comparable biotech deals from other GPs.

Abbisko Healthcare
Active
The Carlyle GroupChina
Adagene
Active
General AtlanticChina
Advanced Cell Diagnostics
Active
Summit PartnersUS
Akero Therapeutics
Akero Therapeutics
Active
General AtlanticUS
Aldevron
Aldevron
Active
TA AssociatesUS
Alloy Therapeutics
Alloy Therapeutics
Active
Mubadala CapitalUS
Track SynAct Pharma

Save this record to your watchlist and pick up your research where you left off. No spam.

Create free account

Who could buy SynAct Pharma?

7 strategic and 113financial buyers match this company's sector and geography profile, ranked from verified European deal history.

Find likely buyers

Get the full record on SynAct Pharma.

Free. No credit card. 30 seconds. Exit buyers and MOIC on Pro.

Hand-checked deal notes on this investment
Save this company to your watchlist
Exit buyer and MOIC on this deal (Pro)
or
Continue with email

Already a member? Sign in

Look up another firm or company
Data refreshed weekly · Sourced from public filings · Report an issue